QingSong Health Corporation (HKG:2661)
Hong Kong · Delayed Price · Currency is HKD 3.810
-0.175 (-4.39%)
Oct 2, 2026, 4:08 PM HKT
QingSong Health Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 957.97 | 1,256 | 945.01 | 489.96 | 393.61 | |
Revenue Growth | -23.11% | 32.90% | 92.87% | 24.48% | - |
Cost of Revenue | 556.6 | 820.74 | 583.38 | 98.49 | 68.44 |
Gross Profit | 401.37 | 435.14 | 361.63 | 391.48 | 325.16 |
Selling, General & Admin | 334.31 | 285.79 | 230.07 | 187.1 | 125.61 |
Research & Development | 93.28 | 75.59 | 72.04 | 61.39 | 52.82 |
Operating Expenses | 428.16 | 361.62 | 302.15 | 248.78 | 178.62 |
Operating Income | -26.79 | 73.52 | 59.48 | 142.7 | 146.54 |
Interest & Investment Income | 10.44 | 6.71 | 10.87 | 9.07 | 8.44 |
Currency Exchange Gain (Loss) | -2.01 | -0.03 | -1.83 | -2.39 | -10.01 |
Other Non Operating Income (Expenses) | -41.84 | -55.56 | -11.16 | 0 | 7 |
EBT Excluding Unusual Items | -60.2 | 24.65 | 57.36 | 149.38 | 151.97 |
Gain (Loss) on Sale of Investments | 1.13 | 0.89 | 0.12 | 3.5 | 5 |
Gain (Loss) on Sale of Assets | - | - | 0.28 | -0.05 | - |
Other Unusual Items | -458.24 | -404.42 | -50.37 | -48.3 | -150.63 |
Pretax Income | -517.31 | -378.88 | 7.38 | 104.54 | 6.34 |
Income Tax Expense | -0.19 | 0.85 | -1.61 | 7.37 | 15.44 |
Earnings From Continuing Operations | -517.12 | -379.72 | 8.99 | 97.17 | -9.1 |
Earnings From Discontinued Operations | - | - | 1.41 | -23.52 | 7.04 |
Net Income | -517.12 | -379.72 | 10.4 | 73.65 | -2.06 |
Net Income to Common | -517.12 | -379.72 | 10.4 | 73.65 | -2.06 |
Net Income Growth | - | - | -85.88% | - | - |
Shares Outstanding (Basic) | 146 | 83 | 80 | 80 | 80 |
Shares Outstanding (Diluted) | 146 | 83 | 101 | 202 | 80 |
Shares Change | -3.85% | -17.96% | -50.09% | 152.68% | - |
EPS (Basic) | -3.54 | -4.58 | 0.13 | 0.92 | -0.03 |
EPS (Diluted) | -3.54 | -4.58 | 0.10 | 0.60 | -0.03 |
EPS Growth | - | - | -82.75% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -133.21 | 81.37 | 82.79 | 7.65 | 57.2 |
Free Cash Flow Per Share | -0.91 | 0.98 | 0.82 | 0.04 | 0.71 |
Gross Margin | 41.90% | 34.65% | 38.27% | 79.90% | 82.61% |
Operating Margin | -2.80% | 5.85% | 6.29% | 29.13% | 37.23% |
Profit Margin | -53.98% | -30.23% | 1.10% | 15.03% | -0.52% |
Free Cash Flow Margin | -13.91% | 6.48% | 8.76% | 1.56% | 14.53% |
EBITDA | -26.27 | 73.95 | 59.7 | 142.99 | 146.99 |
EBITDA Margin | -2.74% | 5.89% | 6.32% | 29.18% | 37.34% |
D&A For EBITDA | 0.52 | 0.43 | 0.23 | 0.29 | 0.45 |
EBIT | -26.79 | 73.52 | 59.48 | 142.7 | 146.54 |
EBIT Margin | -2.80% | 5.85% | 6.29% | 29.13% | 37.23% |
Effective Tax Rate | - | - | - | 7.05% | 243.52% |
Advertising Expenses | - | 177.6 | 129.31 | 107.04 | 48.15 |